Pediatrix Medical (MD) Change in Accured Expenses (2009 - 2026)

Pediatrix Medical (MD) has reported Change in Accured Expenses for 18 consecutive years, with -$5.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 9.53% year-over-year to -$5.6 million; the TTM figure through Mar 2026 stood at $28.9 million (down 42.17% YoY), while the FY2025 annual figure was $28.3 million, down 44.6% from the prior year.
• Change in Accured Expenses slipped to -$5.6 million in Q1 2026 per MD's latest filing, from $41.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $85.3 million in Q4 2024 and bottomed at -$93.1 million in Q2 2023.
• Historically, Change in Accured Expenses has averaged $2.5 million across 5 years, with a median of -$3.3 million in 2025.
• On a YoY basis, Change in Accured Expenses climbed as much as 556.11% in 2023 and fell as far as 579.02% in 2023.
• Pediatrix Medical's Change in Accured Expenses stood at -$9.7 million in 2022, then soared by 556.11% to $44.2 million in 2023, then soared by 92.99% to $85.3 million in 2024, then plunged by 51.99% to $41.0 million in 2025, then plunged by 113.58% to -$5.6 million in 2026.
• Business Quant data shows MD's Change in Accured Expenses at -$5.6 million in Q1 2026, $41.0 million in Q4 2025, and -$3.3 million in Q3 2025.